Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar 11;10(3):657.
doi: 10.3390/biomedicines10030657.

Renal Cell Carcinoma in End-Stage Renal Disease: A Review and Update

Affiliations
Review

Renal Cell Carcinoma in End-Stage Renal Disease: A Review and Update

Ziad M El-Zaatari et al. Biomedicines. .

Abstract

Renal cell carcinoma (RCC) occurring in the setting of end-stage renal disease (ESRD) shows unique clinicopathological characteristics. The two most frequent types of ESRD-associated RCC are acquired cystic kidney disease-associated renal cell carcinoma (ACKD-RCC) and clear-cell papillary renal cell carcinoma (ccpRCC). Other types of RCC also occur in ESRD, albeit with different frequencies from the non-ESRD general population. The histological features of RCC do not vary in the setting of ESRD vs. non-ESRD, yet other findings, such as multifocality and multiple tumor types, are more frequent in ESRD. Studies have generated novel and important knowledge of the etiology, epidemiology, diagnosis, treatment, immunophenotype, and molecular characteristics of ESRD-associated RCC. Knowledge of these data is important for both pathologists and other physicians who may encounter ESRD patients with RCC. This review presents a comprehensive summary and update of the literature on RCC in ESRD, with a focus on the two most frequent types, ACKD-RCC and ccpRCC.

Keywords: acquired cystic kidney disease; acquired cystic kidney disease-associated renal cell carcinoma; clear-cell papillary renal cell carcinoma; end-stage renal disease; end-stage renal disease-associated renal cell carcinoma; immunohistochemistry; molecular pathology; pathology; renal cell carcinoma.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Summary of pathogenesis of RCC in ESRD.
Figure 2
Figure 2
Concurrent ACKD-RCC and ccpRCC in a single kidney. Two tumors occurred simultaneously in this nephrectomy, a ccpRCC (right side of picture, abutting renal capsule) and a smaller ACKD-RCC (central part of picture).
Figure 3
Figure 3
Gross and histological features of ACKD-RCC. (a) ACKD-RCC arising in two foci (arrows) of a kidney with multiple background cysts. (b) Papillary architecture in ACKD-RCC. (c) Calcium oxalate crystals in ACKD-RCC under polarized light. (d) Nests and cords of eosinophilic cells in ACKD-RCC with interspersed calcium oxalate. (e) Characteristic “sieve-like” spaces. (f) Area of an ACKD-RCC, including cells with clear cytoplasm. (Note: (a) gross image, (bf) photomicrographs of hematoxylin and eosin stained sections, (be) 100× magnification, (f) 200× magnification).
Figure 4
Figure 4
Histological features of ccpRCC. (a) Tubular architecture in ccpRCC. (b) Areas with tubular and solid or nested architecture of clear cells. (c) Clear cells with linear arrangement of nuclei and inverse polarization, which have been described as resembling secretory endometrial glands. (d) Cystic septum in ccpRCC with short papillary projections. (Note: Hematoxylin and eosin stained sections, (a,b,d) 100× magnification, (c) 600× magnification).

References

    1. Lv J.C., Zhang L.X. Prevalence and Disease Burden of Chronic Kidney Disease. Adv. Exp. Med. Biol. 2019;1165:3–15. doi: 10.1007/978-981-13-8871-2_1. - DOI - PubMed
    1. Thurlow J.S., Joshi M., Yan G., Norris K.C., Agodoa L.Y., Yuan C.M., Nee R. Global Epidemiology of End-Stage Kidney Disease and Disparities in Kidney Replacement Therapy. Am. J. Nephrol. 2021;52:98–107. doi: 10.1159/000514550. - DOI - PMC - PubMed
    1. Stewart J.H., Vajdic C.M., van Leeuwen M.T., Amin J., Webster A.C., Chapman J.R., McDonald S.P., Grulich A.E., McCredie M.R. The pattern of excess cancer in dialysis and transplantation. Nephrol. Dial. Transplant. 2009;24:3225–3231. doi: 10.1093/ndt/gfp331. - DOI - PubMed
    1. Butler A.M., Olshan A.F., Kshirsagar A.V., Edwards J.K., Nielsen M.E., Wheeler S.B., Brookhart M.A. Cancer incidence among US Medicare ESRD patients receiving hemodialysis, 1996–2009. Am. J. Kidney Dis. 2015;65:763–772. doi: 10.1053/j.ajkd.2014.12.013. - DOI - PMC - PubMed
    1. Ishikawa I. Present status of renal cell carcinoma in dialysis patients in Japan: Questionnaire study in 2002. Nephron. Clin. Pract. 2004;97:c11–c16. doi: 10.1159/000077590. - DOI - PubMed

LinkOut - more resources